News today that the previous owners of the intellectual property that spawned the product we know as Rhofade, have purchased the rights to buy it back from Allergan. So those responsible for creating the company that originally created the oxymetazoline based topical, and then sold it to Allergan in 2011 are now purchasing the product […]
One of the startling outcomes of some research into the true burden of rosacea is just how much life expectancy a sufferer of severe rosacea would be willing to trade for clearance of their symptoms. The study which was commissioned by Galderma has unearthed a striking statistic -many rosacea sufferers who say that their […]
Galderma has created a major publicity campaign around the idea that the burden of suffering from rosacea is bigger than many doctors appreciate. The campaign seeks to create an expectation that all rosacea sufferers ought to reach a self declared `clear’ of their rosaea symptoms, promoting the idea that unless rosacea sufferers are able to […]
A for-sale sign is hanging outside the Galderma shop, shall we make them an offer? The rosacea behemoth that is Galderma could be about to change hands, read on to find out this sale could mean for rosacea sufferers and why we all have an interest in the new owner. Galderma was created in 1981 […]
A phase 2 trial for a topical minocycline gel for the papules and pustules of rosacea has just been listed. BiopharmX, the sponsors of the trial, suggest that the product BPX-04 has “good tolerability and promising efficacy in rosacea” and also showcases “the value of our anhydrous hydrophilic topical delivery system.” The trial will compare the […]
